The Combined Thiotepa and Testosterone Treatment of Cancer of the Breast
1964

Thiotepa and Testosterone Treatment for Breast Cancer

Sample size: 40 publication Evidence: moderate

Author Information

Author(s): I. Scott Brown, W. M. Ross, D. N. Walder

Primary Institution: Royal Victoria Infirmary

Hypothesis

Can a combined regimen of Thiotepa and testosterone be as effective as orthodox treatments for breast cancer?

Conclusion

Thiotepa and testosterone treatment can relieve symptoms and control disseminated breast cancer, comparable to orthodox methods.

Supporting Evidence

  • Both treatment groups had similar demographics and cancer types.
  • Patients treated with Thiotepa and testosterone had fewer slowly-growing tumors.
  • Thiotepa and testosterone treatment resulted in palliation for some patients.
  • Patients who did not respond to Thiotepa and testosterone were unlikely to respond to orthodox treatments.

Takeaway

Doctors tested a new treatment for breast cancer using two drugs, Thiotepa and testosterone, to see if it works as well as traditional treatments.

Methodology

Patients were randomly assigned to receive either Thiotepa and testosterone or orthodox treatments, and their progress was monitored.

Potential Biases

No major differences between groups that could bias results were found.

Limitations

The study had a small sample size and was limited to patients with advanced breast cancer.

Participant Demographics

Patients aged 32 to 68 years with advanced breast cancer.

Statistical Information

Statistical Significance

p > 0.4

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication